nach oben

Seminars in Immunopathology

Erschienen in:

01.07.2015 | Review

Protective and detrimental roles of inflammasomes in disease

verfasst von: Pedro H. V. Saavedra, Dieter Demon, Hanne Van Gorp, Mohamed Lamkanfi

Erschienen in: Seminars in Immunopathology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Over recent years, inflammasomes have emerged as key regulators of immune and inflammatory responses. They induce programmed cell death and direct the release of danger signals and the inflammatory cytokines interleukin (IL)-1β and IL-18. The concerted actions of inflammasomes are of utmost importance for responding adequately to harmful environmental agents and infections. However, deregulated inflammasome signaling is increasingly linked to a diversity of human pathologies, including rheumatoid arthritis, inflammatory bowel disease, and rare, hereditary periodic fever syndromes. In this review, we discuss recent insight in the protective and detrimental roles of inflammasomes in selected infectious, autoinflammatory and autoimmune diseases, and cover clinically approved therapies that interfere with inflammasome signaling. These findings highlight the importance of fine-balancing the Ying and Yang activities of inflammasomes for sustained homeostasis and suggest that further understanding of inflammasome mechanisms may offer new cures for human diseases.

Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137–161PubMed

Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140:805–820PubMed

Broz P, von Moltke J, Jones JW, Vance RE, Monack DM (2010) Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe 8:471–483PubMedCentralPubMed

Van Opdenbosch N, Gurung P, Vande Walle L, Fossoul A, Kanneganti TD, Lamkanfi M (2014) Activation of the NLRP1b inflammasome independently of ASC-mediated caspase-1 autoproteolysis and speck formation. Nat Commun 5:3209PubMedCentralPubMed

Lamkanfi M, Dixit VM (2014) Mechanisms and functions of inflammasomes. Cell 157:1013–1022PubMed

Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550PubMed

Lamkanfi M (2011) Emerging inflammasome effector mechanisms. Nat Rev Immunol 11:213–220PubMed

Brusselle GG, Provoost S, Bracke KR, Kuchmiy A, Lamkanfi M (2014) Inflammasomes in respiratory disease: from bench to bedside. Chest 145:1121–1133PubMed

Clay GM, Sutterwala FS, Wilson ME (2014) NLR proteins and parasitic disease. Immunol Res 59:142–152PubMed

10.

Drummond RA, Gaffen SL, Hise AG, Brown GD (2014) Innate defense against fungal pathogens. Cold Spring Harb Perspect Med. doi:10.1101/cshperspect.a019620 PubMed

11.

Chen I, Ichinohe T (2015) Response of host inflammasomes to viral infection. Trends Microbiol 23:55–63PubMed

12.

Franchi L, Munoz-Planillo R, Nunez G (2012) Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13:325–332PubMedCentralPubMed

13.

Bauernfeind F, Hornung V (2013) Of inflammasomes and pathogens—sensing of microbes by the inflammasome. EMBO Mol Med 5:814–826PubMedCentralPubMed

14.

Tian X, Pascal G, Monget P (2009) Evolution and functional divergence of NLRP genes in mammalian reproductive systems. BMC Evol Biol 9:202PubMedCentralPubMed

15.

Boyden ED, Dietrich WF (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet 38:240–244PubMed

16.

Sastalla I, Crown D, Masters SL, McKenzie A, Leppla SH, Moayeri M (2013) Transcriptional analysis of the three Nlrp1 paralogs in mice. BMC Genomics 14:188PubMedCentralPubMed

17.

Masters SL, Gerlic M, Metcalf D, Preston S, Pellegrini M, O’Donnell JA et al (2012) NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells. Immunity 37:1009–1023PubMedCentralPubMed

18.

Moayeri M, Crown D, Newman ZL, Okugawa S, Eckhaus M, Cataisson C et al (2010) Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment. PLoS Pathog 6:e1001222PubMedCentralPubMed

19.

Terra JK, Cote CK, France B, Jenkins AL, Bozue JA, Welkos SL et al (2010) Cutting edge: resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. J Immunol 184:17–20PubMedCentralPubMed

20.

Pellizzari R, Guidi-Rontani C, Vitale G, Mock M, Montecucco C (1999) Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha. FEBS Lett 462:199–204PubMed

21.

Duesbery NS, Webb CP, Leppla SH, Gordon VM, Klimpel KR, Copeland TD et al (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734–737PubMed

22.

Chavarria-Smith J, Vance RE (2013) Direct proteolytic cleavage of NLRP1B is necessary and sufficient for inflammasome activation by anthrax lethal factor. PLoS Pathog 9:e1003452PubMedCentralPubMed

23.

Hett EC, Slater LH, Mark KG, Kawate T, Monks BG, Stutz A et al (2013) Chemical genetics reveals a kinase-independent role for protein kinase R in pyroptosis. Nat Chem Biol 9:398–405PubMed

24.

Guey B, Bodnar M, Manie SN, Tardivel A, Petrilli V (2014) Caspase-1 autoproteolysis is differentially required for NLRP1b and NLRP3 inflammasome function. Proc Natl Acad Sci U S A 111:17254–17259PubMedCentralPubMed

25.

Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P et al (2014) Inflammatory caspases are innate immune receptors for intracellular LPS. Nature 514:187–192PubMed

26.

Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J et al (2011) Non-canonical inflammasome activation targets caspase-11. Nature 479:117–121PubMed

27.

Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM et al (2012) Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490:288–291PubMedCentralPubMed

28.

Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S et al (2013) Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341:1246–1249PubMed

29.

Knodler LA, Crowley SM, Sham HP, Yang H, Wrande M, Ma C et al (2014) Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens. Cell Host Microbe 16:249–256PubMed

30.

Aachoui Y, Leaf IA, Hagar JA, Fontana MF, Campos CG, Zak DE et al (2013) Caspase-11 protects against bacteria that escape the vacuole. Science 339:975–978PubMedCentralPubMed

31.

Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA (2013) Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341:1250–1253PubMedCentralPubMed

32.

Demon D, Vande Walle L, Lamkanfi M (2014) Sensing the enemy within: how macrophages detect intracellular gram-negative bacteria. Trends Biochem Sci 39:574–576PubMedCentralPubMed

33.

Lage SL, Longo C, Branco LM, da Costa TB, Buzzo Cde L, Bortoluci KR (2014) Emerging concepts about NAIP/NLRC4 inflammasomes. Front Immunol 5:309PubMedCentralPubMed

34.

Rayamajhi M, Zak DE, Chavarria-Smith J, Vance RE, Miao EA (2013) Cutting edge: mouse NAIP1 detects the type III secretion system needle protein. J Immunol 191:3986–3989PubMed

35.

Yang J, Zhao Y, Shi J, Shao F (2013) Human NAIP and mouse NAIP1 recognize bacterial type III secretion needle protein for inflammasome activation. Proc Natl Acad Sci U S A 110:14408–14413PubMedCentralPubMed

36.

Kofoed EM, Vance RE (2011) Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity. Nature 477:592–595PubMedCentralPubMed

37.

Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596–600PubMed

38.

Qu Y, Misaghi S, Izrael-Tomasevic A, Newton K, Gilmour LL, Lamkanfi M et al (2012) Phosphorylation of NLRC4 is critical for inflammasome activation. Nature 490:539–542PubMed

39.

Matusiak M, Van Opdenbosch N, Vande Walle L, Sirard JC, Kanneganti TD, Lamkanfi M (2015) Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5. Proc Natl Acad Sci U S A 112:1541–1546PubMedCentralPubMed

40.

Miao EA, Leaf IA, Treuting PM, Mao DP, Dors M, Sarkar A et al (2010) Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol 11:1136–1142PubMedCentralPubMed

41.

Ceballos-Olvera I, Sahoo M, Miller MA, Del Barrio L, Re F (2011) Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1beta is deleterious. PLoS Pathog 7:e1002452PubMedCentralPubMed

42.

Warren SE, Armstrong A, Hamilton MK, Mao DP, Leaf IA, Miao EA et al (2010) Cutting edge: cytosolic bacterial DNA activates the inflammasome via Aim2. J Immunol 185:818–821PubMedCentralPubMed

43.

Rathinam VA, Jiang Z, Waggoner SN, Sharma S, Cole LE, Waggoner L et al (2010) The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nat Immunol 11:395–402PubMedCentralPubMed

44.

Wu J, Fernandes-Alnemri T, Alnemri ES (2010) Involvement of the AIM2, NLRC4, and NLRP3 inflammasomes in caspase-1 activation by Listeria monocytogenes. J Clin Immunol 30:693–702PubMedCentralPubMed

45.

Sauer JD, Witte CE, Zemansky J, Hanson B, Lauer P, Portnoy DA (2010) Listeria monocytogenes triggers AIM2-mediated pyroptosis upon infrequent bacteriolysis in the macrophage cytosol. Cell Host Microbe 7:412–419PubMedCentralPubMed

46.

Fernandes-Alnemri T, Yu JW, Juliana C, Solorzano L, Kang S, Wu J et al (2010) The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol 11:385–393PubMedCentralPubMed

47.

Xu H, Yang J, Gao W, Li L, Li P, Zhang L et al (2014) Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome. Nature 513:237–241PubMed

48.

Gavrilin MA, Abdelaziz DH, Mostafa M, Abdulrahman BA, Grandhi J, Akhter A et al (2012) Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia. J Immunol 188:3469–3477PubMedCentralPubMed

49.

Rigante D, Vitale A, Lucherini OM, Cantarini L (2014) The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 13:892–900PubMed

50.

Broderick L, De Nardo D, Franklin BS, Hoffman HM, Latz E (2015) The inflammasomes and autoinflammatory syndromes. Annu Rev Pathol 10:395–424PubMed

51.

Masters SL, Simon A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol 27:621–668PubMedCentralPubMed

52.

Chae JJ, Cho YH, Lee GS, Cheng J, Liu PP, Feigenbaum L et al (2011) Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice. Immunity 34:755–768PubMedCentralPubMed

53.

Roldan R, Ruiz AM, Miranda MD, Collantes E (2008) Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine. Joint Bone Spine Rev Rhum 75:504–505

54.

Meinzer U, Quartier P, Alexandra JF, Hentgen V, Retornaz F, Kone-Paut I (2011) Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature. Semin Arthritis Rheum 41:265–271PubMed

55.

Shinkai K, McCalmont TH, Leslie KS (2008) Cryopyrin-associated periodic syndromes and autoinflammation. Clin Exp Dermatol 33:1–9PubMed

56.

Hoffman HM, Wanderer AA, Broide DH (2001) Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 108:615–620PubMedCentralPubMed

57.

Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR et al (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46:2445–2452PubMed

58.

Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI et al (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355:581–592PubMedCentralPubMed

59.

Hoffman HM, Throne ML, Amar NJ, Sebai M, Kivitz AJ, Kavanaugh A et al (2008) Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies. Arthritis Rheum 58:2443–2452PubMed

60.

Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P et al (2009) Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 360:2416–2425PubMed

61.

Meng G, Zhang F, Fuss I, Kitani A, Strober W (2009) A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 30:860–874PubMedCentralPubMed

62.

Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C et al (2009) Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30:875–887PubMedCentralPubMed

63.

Brydges SD, Broderick L, McGeough MD, Pena CA, Mueller JL, Hoffman HM (2013) Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies. J Clin Invest 123:4695–4705PubMedCentralPubMed

64.

Bonar SL, Brydges SD, Mueller JL, McGeough MD, Pena C, Chen D et al (2012) Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS One 7:e35979PubMedCentralPubMed

65.

Sibley CH, Plass N, Snow J, Wiggs EA, Brewer CC, King KA et al (2012) Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes. Arthritis Rheum 64:2375–2386PubMedCentralPubMed

66.

Canna SW, de Jesus AA, Gouni S, Brooks SR, Marrero B, Liu Y et al (2014) An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46:1140–1146PubMedCentralPubMed

67.

Romberg N, Al Moussawi K, Nelson-Williams C, Stiegler AL, Loring E, Choi M et al (2014) Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 46:1135–1139PubMedCentralPubMed

68.

Kitamura A, Sasaki Y, Abe T, Kano H, Yasutomo K (2014) An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med 211:2385–2396PubMedCentralPubMed

69.

Hu Z, Yan C, Liu P, Huang Z, Ma R, Zhang C et al (2013) Crystal structure of NLRC4 reveals its autoinhibition mechanism. Science 341:172–175PubMed

70.

Luksch H, Romanowski MJ, Chara O, Tungler V, Caffarena ER, Heymann MC et al (2013) Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1beta. Hum Mutat 34:122–131PubMed

71.

Lamkanfi M, Kalai M, Saelens X, Declercq W, Vandenabeele P (2004) Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem 279:24785–24793PubMed

72.

Heymann MC, Winkler S, Luksch H, Flecks S, Franke M, Russ S et al (2014) Human procaspase-1 variants with decreased enzymatic activity are associated with febrile episodes and may contribute to inflammation via RIP2 and NF-kappaB signaling. J Immunol 192:4379–4385PubMed

73.

Olson JK, Miller SD (2009) The innate immune response affects the development of the autoimmune response in Theiler’s virus-induced demyelinating disease. J Immunol 182:5712–5722PubMedCentralPubMed

74.

Shaw PJ, McDermott MF, Kanneganti TD (2011) Inflammasomes and autoimmunity. Trends Mol Med 17:57–64PubMedCentralPubMed

75.

Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C et al (2009) Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility. Nat Genet 41:71–76PubMedCentralPubMed

76.

Tamura K, Fukuda Y, Sashio H, Takeda N, Bamba H, Kosaka T et al (2002) IL18 polymorphism is associated with an increased risk of Crohn’s disease. J Gastroenterol 37:111–116PubMed

77.

Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB et al (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med 207:1045–1056PubMedCentralPubMed

78.

Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD (2010) The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32:379–391PubMedCentralPubMed

79.

Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y et al (2011) NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 17:1359–1372PubMedCentralPubMed

80.

Lebeis SL, Powell KR, Merlin D, Sherman MA, Kalman D (2009) Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium. Infect Immun 77:604–614PubMedCentralPubMed

81.

Takagi H, Kanai T, Okazawa A, Kishi Y, Sato T, Takaishi H et al (2003) Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand J Gastroenterol 38:837–844PubMed

82.

Carvalho FA, Nalbantoglu I, Aitken JD, Uchiyama R, Su Y, Doho GH et al (2012) Cytosolic flagellin receptor NLRC4 protects mice against mucosal and systemic challenges. Mucosal Immunol 5:288–298PubMedCentralPubMed

83.

Demon D, Kuchmiy A, Fossoul A, Zhu Q, Kanneganti TD, Lamkanfi M (2014) Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis. Mucosal Immunol 7:1480–1491PubMedCentralPubMed

84.

Williams TM, Leeth RA, Rothschild DE, McDaniel DK, Coutermarsh-Ott SL, Simmons AE et al (2015) Caspase-11 attenuates gastrointestinal inflammation and experimental colitis pathogenesis. Am J Physiol Gastrointest Liver Physiol 308:G139–150PubMed

85.

Oficjalska K, Raverdeau M, Aviello G, Wade SC, Hickey A, Sheehan KM et al (2015) Protective role for caspase-11 during acute experimental murine colitis. J Immunol 194:1252–1260PubMedCentralPubMed

86.

Tobon GJ, Youinou P, Saraux A (2010) The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 9:A288–292PubMed

87.

Hetland ML, Christensen IJ, Tarp U, Dreyer L, Hansen A, Hansen IT et al (2010) Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis Rheum 62:22–32PubMed

88.

Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC (2014) Biologics in Rheumatoid Arthritis G, et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 73:1202–1210PubMed

89.

Yang CA, Huang ST, Chiang BL (2014) Association of NLRP3 and CARD8 genetic polymorphisms with juvenile idiopathic arthritis in a Taiwanese population. Scand J Rheumatol 43:146–152PubMed

90.

Mertens M, Singh JA (2009) Anakinra for rheumatoid arthritis. Cochrane Database Syst Rev CD005121

91.

Vande Walle L, Van Opdenbosch N, Jacques P, Fossoul A, Verheugen E, Vogel P et al (2014) Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature 512:69–73PubMed

92.

Pontillo A, Brandao L, Guimaraes R, Segat L, Araujo J, Crovella S (2010) Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil. Autoimmunity 43:583–589PubMed

93.

Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S et al (2012) Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45:271–278PubMed

94.

Kahlenberg JM, Kaplan MJ (2014) The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? Curr Opin Rheumatol 26:475–481PubMed

95.

Magitta NF, Boe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM et al (2009) A coding polymorphism in NALP1 confers risk for autoimmune Addison’s disease and type 1 diabetes. Genes Immun 10:120–124PubMed

96.

Zhang W, Cai Y, Xu W, Yin Z, Gao X, Xiong S (2013) AIM2 facilitates the apoptotic DNA-induced systemic lupus erythematosus via arbitrating macrophage functional maturation. J Clin Immunol 33:925–937PubMed

97.

Levandowski CB, Mailloux CM, Ferrara TM, Gowan K, Ben S, Jin Y et al (2013) NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1beta processing via the NLRP1 inflammasome. Proc Natl Acad Sci U S A 110:2952–2956PubMedCentralPubMed

98.

Jin Y, Birlea SA, Fain PR, Spritz RA (2007) Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 127:2558–2562PubMed

99.

Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC et al (2007) NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 356:1216–1225PubMed

100.

Zurawek M, Fichna M, Januszkiewicz-Lewandowska D, Gryczynska M, Fichna P, Nowak J (2010) A coding variant in NLRP1 is associated with autoimmune Addison’s disease. Hum Immunol 71:530–534PubMed

101.

Ostendorf B, Iking-Konert C, Kurz K, Jung G, Sander O, Schneider M (2005) Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis. Ann Rheum Dis 64:630–633PubMedCentralPubMed

102.

Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4:542–548PubMed

103.

Voronov E, Dayan M, Zinger H, Gayvoronsky L, Lin JP, Iwakura Y et al (2006) IL-1 beta-deficient mice are resistant to induction of experimental SLE. Eur Cytokine Netw 17:109–116PubMed

104.

Kahlenberg JM, Yalavarthi S, Zhao W, Hodgin JB, Reed TJ, Tsuji NM et al (2014) An essential role of caspase 1 in the induction of murine lupus and its associated vascular damage. Arthritis Rheum 66:152–162

105.

Lech M, Lorenz G, Kulkarni OP, Grosser MO, Stigrot N, Darisipudi MN et al (2014) NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-beta receptor signalling. Ann Rheum Dis. doi:10.1136/annrheumdis-2014-205496 PubMed

106.

Aksentijevich I, DP C, Remmers EF, Mueller JL, Le J, Kolodner RD et al (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 56:1273–1285PubMedCentralPubMed

107.

Neven B, Prieur AM, Quartier dit Maire P (2008) Cryopyrinopathies: update on pathogenesis and treatment. Nat Clin Pract Rheumatol 4:481–489PubMed

108.

Russo RA, Melo-Gomes S, Lachmann HJ, Wynne K, Rajput K, Eleftheriou D et al (2014) Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience. Rheumatology (Oxford) 53:665–670

109.

Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL et al (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779–1785PubMedCentralPubMed

110.

Hoffman HM, Throne ML, Amar NJ, Cartwright RC, Kivitz AJ, Soo Y et al (2012) Long-term efficacy and safety profile of rilonacept in the treatment of cryopryin-associated periodic syndromes: results of a 72-week open-label extension study. Clin Ther 34:2091–2103PubMed

111.

de Koning HD, van Gijn ME, Stoffels M, Jongekrijg J, Zeeuwen PL, Elferink MG et al (2014) Myeloid lineage-restricted somatic mosaicism of NLRP3 mutations in patients with variant Schnitzler syndrome. J Allergy Clin Immunol. doi:10.1016/j.jaci.2014.07.050 PubMed

112.

Lipsker D (2010) The Schnitzler syndrome. Orphanet J Rare Dis 5:38PubMedCentralPubMed

113.

Dwivedi M, Laddha NC, Mansuri MS, Marfatia YS, Begum R (2013) Association of NLRP1 genetic variants and mRNA overexpression with generalized vitiligo and disease activity in a Gujarat population. Br J Dermatol 169:1114–1125PubMed

114.

Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B et al (2014) Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol 170:816–823PubMed

115.

Alkhateeb A, Jarun Y, Tashtoush R (2013) Polymorphisms in NLRP1 gene and susceptibility to autoimmune thyroid disease. Autoimmunity 46:215–221PubMed

116.

Grishman EK, White PC, Savani RC (2012) Toll-like receptors, the NLRP3 inflammasome, and interleukin-1beta in the development and progression of type 1 diabetes. Pediatr Res 71:626–632PubMed

117.

Moran A, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R et al (2013) Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials. Lancet 381:1905–1915PubMed

118.

Schott WH, Haskell BD, Tse HM, Milton MJ, Piganelli JD, Choisy-Rossi CM et al (2004) Caspase-1 is not required for type 1 diabetes in the NOD mouse. Diabetes 53:99–104PubMed

119.

Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KS, McIntire CR, LeBlanc PM et al (2010) Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32:367–378PubMed

120.

Kastbom A, Verma D, Eriksson P, Skogh T, Wingren G, Soderkvist P (2008) Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (the Swedish TIRA project). Rheumatology 47:415–417PubMed

121.

Mathews RJ, Robinson JI, Battellino M, Wong C, Taylor JC, Eyre S et al (2014) Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis 73:1202–1210PubMed

122.

Goldbach-Mansky R (2009) Blocking interleukin-1 in rheumatic diseases. Ann N Y Acad Sci 1182:111–123PubMedCentralPubMed

123.

Matmati M, Jacques P, Maelfait J, Verheugen E, Kool M, Sze M et al (2011) A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat Genet 43:908–912PubMed

124.

Kimkong I, Avihingsanon Y, Hirankarn N (2009) Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR. Lupus 18:1066–1072PubMed

Titel: Protective and detrimental roles of inflammasomes in disease
verfasst von: Pedro H. V. Saavedra
Dieter Demon
Hanne Van Gorp
Mohamed Lamkanfi
Publikationsdatum: 01.07.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: Seminars in Immunopathology / Ausgabe 4/2015
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-015-0485-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2015

Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond

Regulating against the dysregulation: new treatment options in autoinflammation

CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease

Update on genetics and pathogenesis of autoinflammatory diseases: the last 2 years

Advances in the genetically complex autoinflammatory diseases